Outset Medical (NASDAQ:OM) Rating Increased to Buy at CL King

Outset Medical (NASDAQ:OM – Get Free Report) was upgraded by stock analysts at CL King from a “neutral” rating to a “buy” rating in a research note issued to investors on Friday, Marketbeat Ratings reports. The brokerage presently has a $6.00 price target on the stock. CL King’s target price would indicate a potential upside […]

Related Keywords

Canada ,Hong Kong ,United States ,Colorado ,Leslie Trigg ,Marc Nash ,Securities Exchange Commission ,Nisa Investment Advisors ,Hong Kong Ltd ,Royal Bank ,Public Employees Retirement Association Of Colorado ,Outset Medical Inc ,Tower Research Capital ,Outset Medical ,Get Free Report ,Marketbeat Ratings ,Exchange Commission ,Kong Ltd ,Employees Retirement Association ,Investment Advisors ,Research Capital ,Tablo Hemodialysis System ,Outset Medical Daily ,